Multiple forms of cathepsin B in human lung cancer
- PMID: 7705933
- DOI: 10.1002/ijc.2910610109
Multiple forms of cathepsin B in human lung cancer
Abstract
In this study we have examined, by means of isoelectric focusing (IEF) in native polyacrylamide gel and contact-print fluorescence zymography, whether human lung carcinomas and the lung parenchyma contain different pools of multiple charge forms of the cysteine proteinase cathepsin B. The isoelectric point (pI) patterns of cathepsin B from lung carcinoma and matched lung were similar, particularly with regard to 2 major intermediate acidic enzyme pI forms designated as I and II (pIapp of 5.10 and 4.93 in tumors, and 5.11 and 4.94 in lungs, respectively). The slightly acidic cathepsin B pI forms (pIapp 5.47-5.19) in squamous-cell lung carcinoma (SQCLC) were significantly more numerous than such enzyme pI forms in lungs. The numbers of the highly acidic cathepsin B pI forms (pIapp 4.82-4.33) were significantly higher in SQCLC and lung adenocarcinoma (ACL) than in matched lung. The activity distribution percentage in the set of highly acidic cathepsin B pI forms was significantly higher in SQCLC and ACL than in matched lung. We also observed that cathepsin B from SQCLC and matched lung was fully recoverable by IEF from inhibition by leupeptin. Using the cysteine-proteinase-specific inactivator E-64, we revealed by IEF that some cathepsin B isoforms (charge forms) from SQCLC were more resistant to inactivation by this compound than the corresponding enzyme isoforms from lungs. After IEF, the enzyme isoforms apparently lost their resistance to E-64. Our results indicate that the pool of multiple charge forms of cathepsin B in SQCLC and ACL is different from that in the lung, and also that there may be an increased level of loose complexes between cathepsin B and some proteins or polypeptides in SQCLC compared to the lung.
Similar articles
-
Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma.Neoplasma. 1996;43(3):171-8. Neoplasma. 1996. PMID: 8841504
-
Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.Neoplasma. 1997;44(4):219-39. Neoplasma. 1997. PMID: 9473776
-
Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.Neoplasma. 1998;45(5):318-31. Neoplasma. 1998. PMID: 9921922
-
Cathepsin B: multiple enzyme forms from a single gene and their relation to cancer.Enzyme Protein. 1996;49(1-3):94-105. doi: 10.1159/000468619. Enzyme Protein. 1996. PMID: 8797000 Review.
-
Druggable targets of squamous cell lung cancer.Tuberc Respir Dis (Seoul). 2013 Dec;75(6):231-5. doi: 10.4046/trd.2013.75.6.231. Epub 2013 Dec 24. Tuberc Respir Dis (Seoul). 2013. PMID: 24416052 Free PMC article. Review.
Cited by
-
Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis.Br J Cancer. 2004 May 17;90(10):1961-8. doi: 10.1038/sj.bjc.6601830. Br J Cancer. 2004. PMID: 15138478 Free PMC article.
-
Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.Clin Exp Metastasis. 1997 Jul;15(4):368-81. doi: 10.1023/a:1018494020001. Clin Exp Metastasis. 1997. PMID: 9219725
-
Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.Br J Cancer. 1997;75(8):1137-43. doi: 10.1038/bjc.1997.196. Br J Cancer. 1997. PMID: 9099961 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous